Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;107(3):183-93.
doi: 10.1016/j.ad.2015.10.003. Epub 2015 Nov 25.

Review of Cutaneous Graft-vs-Host Disease

[Article in English, Spanish]
Affiliations
Review

Review of Cutaneous Graft-vs-Host Disease

[Article in English, Spanish]
R Ballester-Sánchez et al. Actas Dermosifiliogr. 2016 Apr.

Abstract

Graft-vs-host disease (GVHD) is a multisystem disease that arises as a complication of allogeneic hematopoietic stem cell transplant. It is due to recognition of the recipient's tissues by immune cells from the donor. The skin and mucous membranes are the organs most commonly affected. GVHD is classified as acute or chronic depending on the pathophysiology and clinical presentation. Acute GVHD typically presents with the triad of rash, diarrhea, and hyperbilirubinemia, and treatment is based on systemic corticosteroid and immunosuppressant therapy. The cutaneous manifestations of chronic GVHD are divided into sclerodermiform and nonsclerodermiform, and the mucous membranes and skin appendages may also be affected. The diagnosis is mainly clinical, but skin biopsy can help in doubtful cases. Treatment can be topical, systemic, or physical, depending on the size, site, and depth of the lesions and the involvement of other organs.

Keywords: Cutaneous graft-versus-host disease; Dermatopatología; Dermopathology; Enfermedad injerto contra huésped cutánea; Hematopoietic stem cell transplant; Trasplante de progenitores hematopoyéticos.

PubMed Disclaimer

LinkOut - more resources